106 related articles for article (PubMed ID: 38267642)
1. Author Correction: High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2.
Chan CWF; Wang B; Nan L; Huang X; Mao T; Chu HY; Luo C; Chu H; Choi GCG; Shum HC; Wong ASL
Nat Biomed Eng; 2024 Mar; 8(3):336. PubMed ID: 38267642
[No Abstract] [Full Text] [Related]
2. High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2.
Chan CWF; Wang B; Nan L; Huang X; Mao T; Chu HY; Luo C; Chu H; Choi GCG; Shum HC; Wong ASL
Nat Biomed Eng; 2024 Mar; 8(3):291-309. PubMed ID: 37996617
[TBL] [Abstract][Full Text] [Related]
3. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
[TBL] [Abstract][Full Text] [Related]
4. Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation.
Zhang Q; Tang W; Stancanelli E; Jung E; Syed Z; Pagadala V; Saidi L; Chen CZ; Gao P; Xu M; Pavlinov I; Li B; Huang W; Chen L; Liu J; Xie H; Zheng W; Ye Y
Nat Commun; 2023 Sep; 14(1):5777. PubMed ID: 37723160
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
[TBL] [Abstract][Full Text] [Related]
6. Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.
Rocheleau L; Laroche G; Fu K; Stewart CM; Mohamud AO; Côté M; Giguère PM; Langlois MA; Pelchat M
mBio; 2021 Jun; 12(3):e0078821. PubMed ID: 34182784
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication.
Ali H; Naseem A; Siddiqui ZI
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37763019
[TBL] [Abstract][Full Text] [Related]
8. Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.
Nguyen HT; Zhang S; Wang Q; Anang S; Wang J; Ding H; Kappes JC; Sodroski J
J Virol; 2021 Mar; 95(5):. PubMed ID: 33310888
[TBL] [Abstract][Full Text] [Related]
9. A new screening system for entry inhibitors based on cell-to-cell transmitted syncytia formation mediated by self-propagating hybrid VEEV-SARS-CoV-2 replicon.
Li N; Chen XL; Li Q; Zhang ZR; Deng CL; Zhang B; Li XD; Ye HQ
Emerg Microbes Infect; 2022 Dec; 11(1):465-476. PubMed ID: 35034586
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate promotes ACE2 super-cluster assembly to enhance SARS-CoV-2-associated syncytium formation.
Zhang Q; Tang WC; Stancanelli E; Jung E; Syed Z; Pagadala V; Saidi L; Chen CZ; Gao P; Xu M; Pavlinov I; Li B; Huang W; Chen L; Liu J; Xie H; Zheng W; Ye Y
Res Sq; 2023 Mar; ():. PubMed ID: 37034606
[TBL] [Abstract][Full Text] [Related]
11. A high-throughput screening system for SARS-CoV-2 entry inhibition, syncytia formation and cell toxicity.
Jancy SV; Lupitha SS; Chandrasekharan A; Varadarajan SN; Nelson-Sathi S; Prasad R; Jones S; Easwaran S; Darvin P; Sivasailam A; Santhoshkumar TR
Biol Proced Online; 2023 Jul; 25(1):22. PubMed ID: 37495994
[TBL] [Abstract][Full Text] [Related]
12. The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione.
Murae M; Shimizu Y; Yamamoto Y; Kobayashi A; Houri M; Inoue T; Irie T; Gemba R; Kondo Y; Nakano Y; Miyazaki S; Yamada D; Saitoh A; Ishii I; Onodera T; Takahashi Y; Wakita T; Fukasawa M; Noguchi K
Biochem Biophys Res Commun; 2022 Mar; 597():30-36. PubMed ID: 35123263
[TBL] [Abstract][Full Text] [Related]
13. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.
Cheng YW; Chao TL; Li CL; Chiu MF; Kao HC; Wang SH; Pang YH; Lin CH; Tsai YM; Lee WH; Tao MH; Ho TC; Wu PY; Jang LT; Chen PJ; Chang SY; Yeh SH
Cell Rep; 2020 Oct; 33(2):108254. PubMed ID: 33007239
[TBL] [Abstract][Full Text] [Related]
14. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.
Zhang S; Gao C; Das T; Luo S; Tang H; Yao X; Cho CY; Lv J; Maravillas K; Jones V; Chen X; Huang R
J Immunol Methods; 2022 Apr; 503():113244. PubMed ID: 35218866
[TBL] [Abstract][Full Text] [Related]
15. Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants.
Li C; Huang J; Yu Y; Wan Z; Chiu MC; Liu X; Zhang S; Cai JP; Chu H; Li G; Chan JF; To KK; Yang Z; Jiang S; Yuen KY; Clevers H; Zhou J
Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2300376120. PubMed ID: 37068258
[TBL] [Abstract][Full Text] [Related]
16. A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry.
Xu M; Pradhan M; Gorshkov K; Petersen JD; Shen M; Guo H; Zhu W; Klumpp-Thomas C; Michael S; Itkin M; Itkin Z; Straus MR; Zimmerberg J; Zheng W; Whittaker GR; Chen CZ
SLAS Discov; 2022 Mar; 27(2):86-94. PubMed ID: 35086793
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination.
Zhang Z; Zheng Y; Niu Z; Zhang B; Wang C; Yao X; Peng H; Franca DN; Wang Y; Zhu Y; Su Y; Tang M; Jiang X; Ren H; He M; Wang Y; Gao L; Zhao P; Shi H; Chen Z; Wang X; Piacentini M; Bian X; Melino G; Liu L; Huang H; Sun Q
Cell Death Differ; 2021 Sep; 28(9):2765-2777. PubMed ID: 33879858
[TBL] [Abstract][Full Text] [Related]
18. TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTS.
Cicka D; Niu Q; Qui M; Qian K; Miller E; Fan D; Mo X; Ivanov AA; Sarafianos SG; Du Y; Fu H
J Mol Cell Biol; 2023 Aug; 15(3):. PubMed ID: 36921991
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells.
Yang H; Yuan H; Zhao X; Xun M; Guo S; Wang N; Liu B; Wang H
Virol Sin; 2022 Jun; 37(3):380-389. PubMed ID: 35272059
[TBL] [Abstract][Full Text] [Related]
20. Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples.
Meyrath M; Szpakowska M; Plesseria JM; Domingues O; Langlet J; Weber B; Krüger R; Ollert M; Chevigné A;
Methods Enzymol; 2022; 675():351-381. PubMed ID: 36220277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
